urinary
portersilber
chromogens
following
intravenous
metho
pyrapone
acth
patients
breast
cancer
urinary
portersilber
chromogens
measured
groups
patients
breast
cancer
intravenous
methopyrapone
acth
administration
control
group
consisted
females
free
disease
years
following
mastectomy
study
group
documented
metastatic
disease
significant
difference
urinary
portersilber
chromo
gens
found
groups
day
course
study
within
range
normal
measured
laboratory
concluded
functional
reserve
capacity
pituitary
acth
secretion
adreno
cortical
steroidogenesis
patients
advanced
metastatic
breast
cancer
rela
tively
normal
